Watson Pharmaceuticals, an American maker of generic pharmaceuticals, recently bought its European competitor Actavis. The deal that was finished at the end of October, creating the world's third largest generic pharmaceutical company. The new company takes the name of the latter, and a new corporate identity was unveiled on October 31.
The new corporate identity was developed by Lippincott. The new logo combines a W from the old name with an A from the new company. A press release says is "speaks to the Company's fast-evolving business, as well as its dynamic culture".
One stated reason for shedding the Watson name was that the company can't register it globally, as it is a common surname.
Read more »
Post a Comment
Post a Comment